Her2 L755s Mutation Is Acquired Upon Resistance To Lapatinib And Neratinib And Confers Cross-Resistance To Tucatinib And Trastuzumab In Her2-Positive Breast Cancer Cell ModelsJamunarani Veeraraghavan,Ragini Mistry,Sarmistha Nanda,Vidyalakshmi Sethunath,Martin Shea,Tamika Mitchell,Meenakshi Anurag,Michael A. Mancini,Fabio Stossi,C. Kent Osborne,Mothaffar F. Rimawi,Rachel SchiffCANCER RESEARCH（2021）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
